ABSTRACT
Canine prostate gland is a hormonal dependent organ and its imbalance of estrogen and androgen receptor expressions are directly associated with the development of different diseases. Due to the lack of information regarding the behavior of the aforementioned receptors in canine prostate cancer (PC), this study aimed to identify estrogen receptor alpha (ERα), androgen receptor (AR), Ki67 and phosphatase and tensin homolog (PTEN) protein expressions in canine PC by immunohistochemistry. We found nuclear expression of ERα and AR in the epithelial cells of normal canine samples and a loss of protein expression in PC samples. Normal samples showed Ki67 expression in a few basal cells and the PC samples showed the highest mean of positive cells (253.1). Canine prostate cancer showed a high proliferative index, which was associated with independence of hormonal actuation. PTEN showed positive nuclear and cytoplasmic expression in normal canine samples and a loss in PC. Loss of ERα, AR and PTEN indicated that canine PC exhibits the same immunohistochemical phenotype as in human patients with PC resistant to hormonal therapy. Therefore, canine PC should be considered as a model to study human PC resistant to hormonal therapy.(AU)
A glândula prostática canina é um órgão dependente de hormônio, e o desequilíbrio na expressão dos receptores de estrógeno e andrógeno estão diretamente associados com o desenvolvimento de diferentes doenças. Devido à falta de informação sobre o comportamento desses receptores no câncer prostático canino (PC), este estudo tem por objetivo identificar a expressão proteica através da técnica de imuno-histoquímica do receptor de estrógeno alfa (REα), receptor de andrógeno (RA), Ki67 e fosfatase e tensina homóloga (PTEN). Foi encontrado nas células epiteliais prostáticas normais caninas a expressão nuclear de REα e RA, e perda de expressão proteica nas amostras de PC. As amostras normais apresentaram expressão de Ki67 em poucas células basais e as amostras de PC apresentaram a maior média de células positivas (253,1). O câncer de próstata canino apresentou uma taxa alta de proliferação, o qual foi associado com a atuação independente de hormônio. As amostras de próstatas caninas normais revelaram marcação nuclear e citoplasmática da proteína PTEN e perda nas amostras de PC. A perda de REα, RA e PTEN indicam que as amostras de PC exibem o mesmo fenótipo imuno-histoquímico de pacientes humanos com câncer prostático resistente a terapia hormonal. Sendo assim, o PC canino deve ser considerado um modelo para estudos de câncer prostático humano resistente a terapia hormonal.(AU)
Subject(s)
Animals , Dogs , Prostate/pathology , Prostatic Hyperplasia/veterinary , Prostatic Neoplasms/veterinary , Prostatic Intraepithelial Neoplasia/veterinary , Dogs , Receptors, Androgen , Receptors, Cytoplasmic and Nuclear , Estrogen Receptor alpha , Disease Models, Animal , Prostatic Neoplasms, Castration-Resistant/veterinaryABSTRACT
Arsenic is a testicular environmental toxic. Melatonin (Me), being a potent antioxidant, may reduce the damage caused by arsenic in male fertility. The effects of daily oral exposure of Sodium Arsenite (As; 7.0 mg/kg/bw); Melatonin (Me, 10.0 mg/kg/bw); Me (10.0 mg/kg/bw) plus As (7.0 mg/kg/bw), and Negative Control (NaCl 0.9 percent) in male CF-1 adult mice were assessed in acute (8.3 days), chronic (33.2 days) and recovery (66,4 days) of testicular damage. We evaluated changes in testicular weight and histopathological, morphometric measurements, expression of COX-2 and Androgen Receptor (AR) antigens and lipid peroxidation levels. Treatment resulted in decreased tubular diameter and AR expression, and increased: interstitial area, luminal diameter, COX-2 expression levels and of lipid peroxidation. Co-administration of As and Me partially decreased germ cell degeneration and AR expression levels, improving testicular histopathological parameters. These results indicate that As causes toxicity and testicular germ cell degeneration by induction of oxidative stress. Me partially protects from this damage in mouse testis, acting as scavenger of oxygen radical species.
El arsénico es un tóxico testicular ambiental. La melatonina (Me), que es un potente antioxidante, puede reducir el daño causado por el arsénico en la fertilidad masculina. Se evaluaron los efectos de la exposición oral diaria de arsenito de sodio (As; 7,0 mg/kg/peso corporal), melatonina (Me, 10,0 mg/kg/p.c.); Me (10,0 mg/kg/p.c.) más As (7,0 mg/kg/pc) y el Control Negativo (NaCl 0,9 por ciento) en ratones adultos CF-1 machos, a los 8,3 días (exposición aguda), 33,2 días (crónica) y 66,4 días (recuperación) del daño testicular. Se evaluaron los cambios en el peso testicular y mediciones morfométricas, histopatológicas, expresión de COX-2, del receptor de andrógeno (AR) y los niveles de peroxidación de lípidos. El tratamiento con As resultó en disminución del diámetro tubular y la expresión de AR, y el aumento de: área intersticial, diámetro luminal, los niveles de expresión de COX-2 y peroxidación lipídica. La co-administración de As y Me disminuyó parcialmente la degeneración de células germinales, el aumento de los niveles de expresión de AR y hubo mejoría de los parámetros histopatológicos testiculares. Estos resultados indican que As es tóxico y causa degeneración de células germinales por inducción de estrés oxidativo. Me protege parcialmente este daño en los testículos de ratones, actuando como eliminador de especies radicalarias del oxígeno.